- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06992011
- Original Trial
A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia
May 19, 2025 updated by: Shanghai Zhongshan Hospital
To evaluate and compare the clinical efficacy, biomechanical stability, and optical quality of SMILE and SMILE Xtra procedures in patients with myopia through a randomized controlled trial
Study Overview
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Cong Jing
- Phone Number: 17269769976
- Email: lucky_congjing@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Zhongshan Hospital
-
Contact:
- Cong Jing
- Phone Number: 17269769976
- Email: lucky_congjing@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-50 years
- MRSE (Manifest Refraction Spherical Equivalent) -6.00D to -10.00D with refractive changes within ±0.50D in past 2 years
- CDVA (Corrected Distance Visual Acuity) ≥ 20/25
- Myopia progression ≤ 0.50D/year for ≥2 years
- RST (Residual Stromal Thickness) ≥ 250μm after lenticule removal
- Contact lens discontinuation as per protocol
Exclusion Criteria:
- Other eye diseases (keratoconus, glaucoma, etc.)
- Corneal scarring, cataracts affecting observation
- Systemic diseases affecting surgery compliance
- Prior ocular surgeries
- Pregnancy, breastfeeding, or menstruation
- Drug allergies to surgical medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: SMILE Group
|
Small Incision Lenticule Extraction
|
|
Experimental: SMILE Xtra Group
|
Small Incision Lenticule Extraction combined with Corneal Cross-linking (SMILE Xtra)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
visual acuity
Time Frame: 1 week, 1 month,3 months, 6 months, 12 months, 24 months, and 36 months
|
1 week, 1 month,3 months, 6 months, 12 months, 24 months, and 36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
May 19, 2025
First Submitted That Met QC Criteria
May 19, 2025
First Posted (Actual)
May 28, 2025
Study Record Updates
Last Update Posted (Actual)
May 28, 2025
Last Update Submitted That Met QC Criteria
May 19, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2024-267R-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on SMILE
-
Shanghai Zhongshan HospitalRecruiting
-
Eye Hospital Pristina KosovoEnrolling by invitationMyopia | PseudophakiaKosovo
-
Eye Hospital Pristina KosovoEnrolling by invitationMyopia | Hyperopia | PseudophakiaKosovo
-
Carl Zeiss Meditec AGIn Vitro Research Solutions Pvt Ltd (iVRS)CompletedAstigmatism | MyopiaGermany, India, Denmark, Hong Kong
-
Yonsei UniversityCompletedMyopic AstigmatismKorea, Republic of
-
Singapore Eye Research InstituteRecruiting
-
Yonsei UniversityCompleted
-
Carl Zeiss Meditec AGUnknownHypermetropiaChina, Czechia, France, Germany, India, United Kingdom
-
Eye Hospital Pristina KosovoEnrolling by invitationStromal KeratitisKosovo
-
Eye Hospital Pristina KosovoEnrolling by invitation